Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial - Wikidata - awgldk - TriplyDB

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

http://www.wikidata.org/entity/Q34017829

about

Extreme Procalcitonin Elevation without Proven Bacterial Infection Related to Amphetamine Abuse Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit suPAR as a prognostic biomarker in sepsis Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.Advances in Intra-abdominal Sepsis: What Is New?Biomarker discovery and development in pediatric critical care medicine.Using Procalcitonin to Guide Antibiotic Therapy.Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis Biomarker-guided antibiotic therapy-strengths and limitations Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.A focus on intra-abdominal infections.Top stories of 2009.Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up New approaches to sepsis: molecular diagnostics and biomarkers.Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysis Interventions to improve antibiotic prescribing practices for hospital inpatients.Procalcitonin levels associate with severity of Clostridium difficile infection Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic dur Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis.The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated).Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance.

P2860

Q21284729-0CAC555B-49C3-4346-9FF3-5BF387F42941 Q24187768-98DDE94C-671C-4797-8833-ADF90DB4AC3F Q24198268-1CEF5B29-4DDA-472A-9C31-8B43D7324C6E Q24200676-52F02E54-0C69-48D6-A528-C1B4466D93D8 Q24235566-E8735E3B-BAAB-4047-90AE-71533F4AD0C3 Q24236108-12DB9B42-9A45-4454-8F76-BDD9A65E1C63 Q26739860-C3F8906C-EEFF-46F2-A075-E3D884571454 Q26798459-68277AC5-E60C-4727-8E33-4E58C1C1D327 Q26858996-822C106A-F94B-4F4A-ADB9-BC5D50D37428 Q27028085-604DA60D-F7D8-4846-B930-52E1F2C33B07 Q28077765-639B42FC-633E-4FC2-AB92-D40B910FE3ED Q30238953-DEA0102F-DB95-4FCD-85C8-71B84509C3E3 Q30279142-2B298A4C-A938-46F2-B329-10F43842D70E Q30428168-E06B4BCB-5D9A-4D5E-AC27-B317C5A962CF Q33629591-7D848046-7EFE-462E-AAF8-9B3D1A916E5A Q33709127-20F66472-C607-4386-8312-2562F3E85A81 Q33747590-8FD98527-83D6-419E-A6B8-86F729611B44 Q33750023-002AA04C-6DC5-4226-83B5-3A33375ECE96 Q33754533-1B6B1A0D-91DC-4D45-8517-860E98B07CA6 Q33763449-C9A9248C-2AF6-4C0D-B596-AE863C646D2F Q33923936-E9FD3A1F-8F4F-4824-80FA-8FE4FBE8571F Q34026963-05588806-A035-4FAB-B0C5-66878BB54846 Q34027944-E4D633C1-BB2B-42F8-9DEF-E37A867F730D Q34264291-3AE054DE-6519-43B9-B8A3-40DFF338AFAA Q34271299-64293F65-312F-4755-A19E-25971C2C43BB Q34303687-AED25631-6F77-4CE2-A5AE-E301FAAB30CF Q34337138-3626CA05-B87D-49C4-A04B-71200953404A Q34550823-365C520E-31F6-462F-925F-BA0FD7C6FE29 Q34625689-C8196E0E-5D82-429E-94CA-F99698ADF90E Q34645044-68ACC168-E681-4353-9854-1BAD0D750EF2 Q34670419-AFB505F2-7F7B-45C7-9A63-87239D7C5F45 Q35007561-A77D0748-5319-4745-BAC9-950786B91C5C Q35068408-42DB2DA7-DA8F-457D-8646-91A22885F532 Q35080067-B6A99FCB-B928-4739-9D8E-D2C0D91789B3 Q35110932-66DA8A44-B922-4A05-817A-2EA7ACAC5477 Q35195245-3B03843B-CF81-42E4-9D72-D706FCBC32BD Q35561206-074ECE7B-A2E8-419E-A415-44C19933096E Q35561237-555CD300-09C4-4CF4-8AA2-279D132A9767 Q35958759-3591E6A4-861C-48B7-8A2C-CD53F6864004 Q36067274-470BD477-A13C-4058-B360-22267BA9F5A9

P2860

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

http://www.wikidata.org/entity/Q34017829

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Procalcitonin to guide duratio ...... d prospective controlled trial

@ast

Procalcitonin to guide duratio ...... d prospective controlled trial

@en

Procalcitonin to guide duratio ...... d prospective controlled trial

@nl

type

label

Procalcitonin to guide duratio ...... d prospective controlled trial

@ast

Procalcitonin to guide duratio ...... d prospective controlled trial

@en

Procalcitonin to guide duratio ...... d prospective controlled trial

@nl

prefLabel

Procalcitonin to guide duratio ...... d prospective controlled trial

@ast

Procalcitonin to guide duratio ...... d prospective controlled trial

@en

Procalcitonin to guide duratio ...... d prospective controlled trial

@nl

P1433

Q34017829-57E651CC-1D9C-4FC5-8495-69A070056ED9

P1476

Q34017829-3B5AF3D6-644C-4A1A-A292-3F331AC29919

P2093

Q34017829-263C9DE2-12F9-4D4B-9EF7-7A4E673BF5C1

Q34017829-33678A02-7FF8-4787-90BF-97FF43713482

Q34017829-5CEDBC33-EA91-4773-98A9-28B9C0FE55BC

Q34017829-71E56E52-F54F-4324-92D5-C71DE7EB6B42

Q34017829-9AB334EC-5A4E-4066-BB55-563A550BC725

Q34017829-C8FF5750-E6BC-4CD6-BC40-A64A9C98FA7A

Q34017829-E292BBF4-C35B-4BF8-AEE3-17000822E271

P2860

Q34017829-0C09A03F-1939-4E63-9CE4-3107659472CC

Q34017829-0DF14621-1E37-45CC-AAEF-998CF41D5E31

Q34017829-103C513B-B62E-46E9-A23B-E2C8D7B5710C

Q34017829-166B286E-DD70-4A25-89BD-2CDAB63210F0

Q34017829-16FB88D6-DEAA-45BD-BA9C-24100E9FE287

Q34017829-245EE268-70C2-416A-8244-67B472D2C23C

Q34017829-326D2F36-591F-4653-B8E1-1BAAD24D4E38

Q34017829-630BDA8D-2ACB-4EFC-BC1C-F0B204A27349

Q34017829-63CACB7C-2C75-485A-9115-C88E2E7CE01C

Q34017829-7E056BC8-323A-47D9-9DF9-8927E9031B1B

P2888

Q34017829-CEAB0189-CD8B-41B3-968A-4107F75163A1

P304

Q34017829-7D67B145-D36C-4B4C-8A56-ED5D84A90ADB

P31

Q34017829-A2A0B2F2-18D7-471D-A4A6-D4C47D7EE91A

P356

Q34017829-644EC39F-52AA-45A5-B893-48ACC372760B

P433

Q34017829-33B354B7-AB23-42F7-BAE9-532B1F57D3C9

P478

Q34017829-11E93A65-687D-4315-96E9-6E842F0E8694

P577

Q34017829-9B6E0F65-01E4-43BA-8190-3CA1BCC392C4

P5875

Q34017829-1E174634-66B1-4F67-8F25-FB13A62712A9

P6179

Q34017829-48F793DD-544B-4C99-B43B-B64470F737C2

P698

Q34017829-819477A2-3610-43CD-BA6E-66FC4DBD91C6

P921

Q34017829-91E6F485-1268-4F48-A6B1-459A6F7636F3

P932

Q34017829-091707B1-43A8-487B-B68F-F9380DF502DF

P356

P1433

P1476

Procalcitonin to guide duratio ...... d prospective controlled trial

@en

P2093

Anna Maria Schweiger

http://www.w3.org/2001/XMLSchema#string

Berthold Bein

http://www.w3.org/2001/XMLSchema#string

Fritz Sixtus Keck

http://www.w3.org/2001/XMLSchema#string

Marcel Hochreiter

http://www.w3.org/2001/XMLSchema#string

Stefan Schroeder

http://www.w3.org/2001/XMLSchema#string

Thomas Köhler

http://www.w3.org/2001/XMLSchema#string

Tilman von Spiegel

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription.

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Procalcitonin in bacterial infections--hype, hope, more or less?

Optimizing antibiotic treatment for ventilator-associated pneumonia.

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Epidemiology of sepsis in Germany: results from a national prospective multicenter study.

Body temperature alterations in the critically ill.

Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables.

P2888

P304

R83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC7903

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26263788

http://www.w3.org/2001/XMLSchema#string

P6179

1031777631

http://www.w3.org/2001/XMLSchema#string

P698

19493352

http://www.w3.org/2001/XMLSchema#string

P921

P932

2717450

http://www.w3.org/2001/XMLSchema#string